Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,047 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial.
Fu H, Sun X, Lin R, Wang Y, Xuan L, Yao H, Zhang Y, Mo X, Lv M, Zheng F, Kong J, Wang F, Yan C, Han T, Chen H, Chen Y, Tang F, Sun Y, Chen Y, Xu L, Liu K, Zhang X, Liu Q, Huang X, Zhang X. Fu H, et al. Among authors: zheng f. BMC Med. 2024 Feb 27;22(1):85. doi: 10.1186/s12916-024-03275-5. BMC Med. 2024. PMID: 38413930 Free PMC article. Clinical Trial.
[Comparison of clinical features of hemorrhagic cystitis after haploidentical and matched sibling donor allogeneic hematopoietic stem cell transplantation].
Zheng FM, Fu HX, Han TT, Wang FR, Wang JZ, Chen Y, Yan CH, Zhang YY, Han W, Chen YY, Chen H, Wang Y, Zhang XH, Liu KY, Huang XJ, Xu LP. Zheng FM, et al. Zhonghua Xue Ye Xue Za Zhi. 2017 Aug 14;38(8):656-661. doi: 10.3760/cma.j.issn.0253-2727.2017.08.002. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28954342 Free PMC article. Chinese.
Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantation.
Kong J, Zheng FM, Wang ZD, Zhang YY, Cheng YF, Fu HX, Lv M, Chen H, Xu LP, Zhang XH, Huang XJ, Wang Y. Kong J, et al. Bone Marrow Transplant. 2023 Jul;58(7):777-783. doi: 10.1038/s41409-023-01973-x. Epub 2023 Apr 6. Bone Marrow Transplant. 2023. PMID: 37024571
FLT3-ITD Allelic Ratio and NPM1 Mutation Do Not Impact Outcomes in Acute Myeloid Leukemia Patients with FLT3-ITD after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Propensity Score- Matching Study.
Zhou C, Zheng F, Xu L, Zhang X, Chang Y, Mo X, Sun Y, Huang X, Wang Y. Zhou C, et al. Among authors: zheng f. Transplant Cell Ther. 2023 Jul;29(7):456.e1-456.e11. doi: 10.1016/j.jtct.2023.03.033. Epub 2023 Apr 5. Transplant Cell Ther. 2023. PMID: 37028555
Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experience.
Ma R, Zhu DP, Zhang XH, Xu LP, Wang Y, Mo XD, Lv M, Zhang YY, Cheng YF, Yan CH, Chen YH, Chen Y, Wang JZ, Wang FR, Han TT, Kong J, Wang ZD, Han W, Chen H, Chang YJ, He Y, Xu ZL, Zheng FM, Fu HX, Liu KY, Huang XJ, Sun YQ. Ma R, et al. Bone Marrow Transplant. 2024 Apr 2. doi: 10.1038/s41409-024-02276-5. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38565964
4,047 results